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Intrapartum asphyxia and consequent neonatal hypoxic ischaemic 
encephalopathy (NHIE) is a problem in low- and middle-income 
countries (LMICs). It has been suggested that <10% of cases 
of cerebral palsy (CP) in high-income countries are caused by 
intrapartum asphyxia.[1] However, intrapartum asphyxia may be the 
cause of up to 42% of CP cases in LMICs.[2] The strong relationship 
between CP and intrapartum asphyxia in LMICs may be due to 
under-resourcing and lack of access to appropriate health facilities. 
The incidence of NHIE varies considerably, with the greatest burden 
occurring in sub-Saharan Africa (14.9 per 1 000 live births) and much 
lower rates (1.5 per 1 000 live births) in high-income countries.[3] 
Results from previous studies conducted in tertiary referral centres 
in South Africa (SA) have demonstrated NHIE rates of 2.3 - 13.3 
per 1 000 live births.[4-6] The rate of NHIE is likely to be considerably 
higher in rural areas, where there are relatively high levels of home 
births and health facilities are often under-resourced.
Therapeutic hypothermia (TH) improves the outcomes associated 
with NHIE. A Cochrane review of 11 studies demonstrated that 
TH reduces both death and major neurodevelopmental disability.[7] 
Although there is some controversy regarding the safety and benefits 
of TH in LMICs,[8] it has been provided in the public sector in SA for 
several years.
There is a lack of information on developmental outcomes in 
survivors of NHIE in SA. A retrospective review conducted in 
Johannesburg reported that 79.6% of survivors of NHIE were 
neurologically normal on follow-up, with a CP incidence of 13.2%.[4] 
However, no formal neurodevelopmental assessment was performed, 
and information about developmental outcomes was available for 
fewer than one-third of the neonates. Accurate information on 
developmental outcomes and rates of disability in survivors of 
NHIE is needed to enable planning of further research and to make 
judgements on the merits of health interventions such as TH.
Objectives
To compare developmental outcomes in survivors of NHIE with 
those in healthy children born at full term in a hospital in SA.
Methods
A prospective, observational study was conducted at a tertiary 
referral hospital in Johannesburg. Mothers of infants who had 
survived NHIE and had been discharged from the hospital’s neonatal 
unit between June 2013 and December 2016 were invited to participate 
in the follow-up study. Those who presented at the follow-up clinic 
and provided consent to participate were enrolled.
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Background. Neonatal hypoxic ischaemic encephalopathy (NHIE) is an important cause of long-term handicap in survivors. There is 
limited information on the burden of handicap from NHIE in sub-Saharan Africa.
Objectives. To determine the developmental outcomes in survivors of NHIE in South Africa (SA).
Methods. In this prospective observational study, the developmental outcomes in 84 infants who had survived hypoxic ischaemic 
encephalopathy (the NHIE group) were compared with those in 64 unaffected infants (the control group). The Bayley Scales of Infant 
Development version III were used for assessment of developmental outcomes.
Results. Significant differences were found between the developmental outcomes of the two groups, with a significantly lower composite 
language score and higher proportions with language, motor and cognitive developmental delays in the NHIE group than in the control 
group. Cerebral palsy (CP) was present in 13 of the infants with NHIE (15.5%) and none in the control group (p<0.001). CP was associated 
with developmental delay, and also with the severity of NHIE. Therapeutic hypothermia (TH) was administered in 58.3% of the study group, 
but although it was associated with lower rates of CP and developmental delay than in the group without TH, the only significant difference 
was for delay on the language subscale.
Conclusions. Survivors of NHIE in SA are at risk of poor developmental outcomes.
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NHIE was diagnosed in neonates with evidence of encephalopathy 
and perinatal asphyxia, as listed below under eligibility criteria 
for cooling. The stage of NHIE (grades 1 - 3) was assessed by the 
attending paediatric staff, as described previously.[9] Infants who were 
not assigned an NHIE grade at birth were excluded from the study.
Whole-body cooling was available on a limited basis during the 
study period. In each case, the attending paediatrician’s decision to 
initiate TH was based on the unit protocol and the availability of 
a cooling machine. The unit protocol, which was modified from 
that used in the TOBY study, has been described elsewhere. [10,11] 
Eligibility criteria for cooling were birthweight >2 000 g, gestational 
age >36 weeks, a history suggestive of perinatal asphyxia, and at least 
one of the following conditions: the need for ongoing resuscitation 
at birth for >10 minutes, evidence of metabolic acidosis (base excess 
≤16 mmol/L) on a blood-gas test performed within 1 hour of birth, a 
10-minute Apgar score <5, and clinical evidence of encephalopathy. 
Neither amplitude-integrated electroencephalography (aEEG) nor 
magnetic resonance imaging (MRI) was available during the study 
period. Cranial ultrasonography was available at most times, but its 
availability was not a factor that was considered when determining 
eligibility for inclusion in the study. When used, TH was initiated 
within 6 hours of birth, in a high-care (level 2) ward. A servo-
controlled cooling mattress was used, and the target rectal temperature 
was 32 - 34°C, with gradual rewarming after 72 hours. Neonates with 
asphyxiation were not routinely provided with mechanical ventilation, 
according to the unit’s neonatal intensive care admission policy, 
so neonates with severe asphyxia who were apnoeic and required 
ventilation were not considered suitable candidates for TH.
Infants were seen at a dedicated follow-up clinic every 3 months. 
Neurodevelopmental assessments were performed by either an 
appropriately trained physiotherapist or a paediatrician, using the 
Bayley Scales of Infant Development version III (BSID-III) at 9 - 
12 months of age, and then again at 15 - 18 months. The assessor 
was not aware of the group classification (NHIE or control). The 
different observers’ assessments had a Cronbach’s alpha intra-class 
correlation of 0.89. The initial BSID-III assessment was performed in 
anticipation of infants failing to attend follow-up visits after the age of 
12 months. The most recent BSID-III assessment for each participant 
was used in the data analysis.
CP was defined as a permanent, non-progressive disorder in the 
development of movement and posture, which in this study was 
attributed to neonatal NHIE.[12]
The study co-ordinator sent parents of participants text messages 
to remind them of appointments, to achieve a good rate of follow-
up. The parents were reimbursed for their transport costs at each 
visit that they attended. The study co-ordinator contacted defaulters 
by telephone and rescheduled the appointments. If a BSID-III 
assessment was missed, the assessment was performed at the next 
follow-up visit that the infant attended. Infants who were noted to 
have developmental problems were referred to the appropriate allied 
medical services for treatment.
A group of full-term infants born at the same hospital who were 
not admitted at birth has been described previously.[13] The infants in 
the NHIE study group were assessed at a younger mean age than the 
overall mean in the previously described control group, so a subgroup 
of 64 healthy, full-term infants who had been tested at the same age 
as the NHIE study group was used as the control group in this study.
Ethical considerations
The study was approved by the Human Research Ethics Committee 
of the University of the Witwatersrand (ref. no. M120623). Written 
informed consent for participation was obtained from each parent 
prior to the infant’s enrolment in the study.
Data collection
Demographics, labour room details, clinical characteristics and 
developmental assessment results were collected for each participant. 
The data were entered into a computerised database hosted by the 
University of the Witwatersrand using Research Electronic Data 
Capture (REDCap) (https://www.project-redcap.org/).[14] Data will 
be made available on reasonable request to the corresponding author 
(DEB).
Sample size
The BSID-III normative population has a mean score of 100 with a 
standard deviation (SD) of 15 for each subscale. On the basis of the 
assumption that the mean score of the study population was 89, with 
an SD of 15, a minimum sample size of 30 in each group would be 
required to detect a statistically significant difference between the 
means, with α=0.05 and β=0.80. Previous follow-up studies in the 
same population have shown a 25% default rate, so the required 
group size was adjusted to 38 participants.
Statistical analysis
Data were analysed using SPSS version 24 (IBM Corp., USA). 
Continuous data that were normally distributed were summarised 
by means and 95% confidence intervals (CIs), whereas categorical 
data were summarised by frequencies and percentages. The BSID-III 
assesses development in the cognitive, language and motor domains. 
We compared the composite BSID-III scores for each domain 
between the control and study groups using independent t-tests and 
χ2 tests, as appropriate. A mean composite score <85 was defined as 
‘at risk’ and a mean composite score <70 as ‘delayed’.[13] The number 
of infants who were at risk or delayed, and the number with CP, were 
compared between the two groups. Results with p-values <0.05 were 
considered statistically significant.
Results
Among 99 infants who attended at least one follow-up clinic visit, 
87 had at least one BSID-III assessment, but 3 did not have a grade 
of NHIE assigned at birth and were excluded. The final sample 
therefore comprised 84 infants who had at least one BSID-III 
assessment, corresponding to a follow-up rate of 84.8%. The BSID-
III assessments were performed at a mean age of 14.31 months 
(95% CI 13.27 - 15.34). The mean gestational age of the infants who 
survived NHIE was 38.98 weeks (95% CI 38.45 - 39.51), while that 
of the control group was 39.52 weeks (95% CI 39.12 - 39.91). The 
mean birthweight of the NHIE group was 3 090 g (95% CI 2 950 - 
3 230) and that of the control group was 2 740 g (95% CI 2 640 - 
2 890 g). The majority of infants were male (60/84; 71.4%). NHIE 
grade 1 was present in 14 of the infants (16.7%), with grade 2 in 56 
(66.7%) and grade 3 in 14 (16.7%). TH was administered in 49 of 
the infants (58.3%). Additional data from the study population are 
shown in Table 1.
The mean composite scores for the BSID-III cognitive, language 
and motor subscales for NHIE survivors and controls are shown in 
Table 2. The only significant difference between the groups was for 
the language subscale, on which the control group had a higher score 
than the study group (p=0.001).
The numbers of participants classified as at risk or delayed were 
significantly greater in the NHIE group than in the control group 
for each subscale, with the exception of the numbers at risk on the 
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cognitive subscale (Table 3). None of the participants in the control 
group were classified as delayed.
The number of participants in the NHIE group who had CP (n=13; 
15.5%) was significantly higher than the number in the control group 
(n=0) (p<0.001). There was no information available on the types 
of CP. Among the 13 infants with CP, 12 were classified as delayed 
on the BSID-III motor subscale, and 1 as at risk. Only 1 infant with 
motor delay did not have evidence of CP. Eight of the infants with 
CP had global delay (classified as delay in the cognitive, motor and 
language domains), and 2 of them were also blind. None of the infants 
without CP had global delay. The grade of NHIE was not significantly 
associated with the incidence of CP. One of the 14 infants with NHIE 
grade 1 (7.1%) had CP, compared with 9 of the 56 infants with NHIE 
grade 2 (16.1%) and 3 of the 14 infants with NHIE grade 3 (21.4%) 
(p=0.566, χ2 analysis).
The numbers of individuals in the NHIE group who had CP or 
delay on the BSID-III subscales were analysed according to whether 
or not TH had been used (Table 4). There were fewer infants with 
CP or delay in the group who had received TH compared with those 
who had not; however, the only significant difference occurred with 
the language subscale (p=0.04).
Discussion
The results of our study in Johannesburg have provided important 
information about developmental outcomes in infants who survive 
NHIE. Rates of CP and developmental delays determined by the 
cognitive, motor and language subscales of the BSID-III were all 
significantly higher in survivors of NHIE than in a control group. 
The rate of CP that we found in the NHIE survivors was slightly 
higher than that previously reported at the same location,[4] and much 
higher than the rate previously found to be associated with preterm 
birth.[15,16] These results suggest that perinatal asphyxia is the most 
important cause of CP in sub-Saharan Africa. Measures to prevent 
perinatal asphyxia and to treat neonates who sustain NHIE should 
therefore be prioritised.
We observed increasing rates of CP as the grade of NHIE 
increased, but this relationship was not statistically significant, 
possibly because of the limited numbers in the study group. The 
overall rate of CP in our NHIE group (15.5%) was similar to a 
previous report indicating that up to one in every six neonates with 
moderate-to-severe NHIE will develop CP.[17]
The burden of handicap in survivors of NHIE is profound. In the 
present study, >60% of children with CP had global developmental 
problems, with associated cognitive and language handicap, and in 
some cases blindness. It is very unlikely that these affected individuals 
will ever be able to live independently, and they will almost certainly 
require ongoing lifelong care. Perinatal asphyxia not only results in 
neurological handicap in survivors but is the most common cause 
of early death in neonates with birthweight >1 000 g,[18] and is a 
factor that contributes to the ever-increasing burden of medicolegal 
litigation. It is therefore important to prioritise interventions to 
Table 1. Baseline characteristics of 84 infants who survived 
neonatal hypoxic ischaemic encephalopathy
Variable n (%)
Born in the study hospital 69 (82.1)
Primipara 26 (31.0)
Maternal hypertension 4 (4.8)
Maternal HIV 18 (21.4)
Teenage mother 2 (2.4)
Mode of delivery
Normal vaginal 39 (46.4)
Assisted vaginal 6 (7.1)
Vaginal breech 6 (7.1)
Caesarean section 43 (51.2)
5-minute Apgar score <6 51 (60.7)
Resuscitation at birth 61 (73.5)
Early-onset sepsis 1 (1.2)
Abnormal cranial ultrasound scan 4 (4.8)
Meconium aspiration syndrome 5 (6.0)
Nasal CPAP 2 (2.4)
Mechanical ventilation 1 (1.2)
Late-onset sepsis 5 (6)
CPAP = continuous positive airway pressure ventilation.
Table 2. Mean composite BSID-III subscale scores for 84 infants with neonatal hypoxic ischaemic encephalopathy (NHIE group) 
and 64 unaffected infants (control group)
           NHIE group         Control group
Variable Mean 95% CI Mean 95% CI p-value*
Age (months) 14.3 13.3 - 15.3 13.6 12.6 - 14.6 0.140
Cognitive score 93.4 88.8 - 97.9 92.5 89.5 - 95.5 0.840
Language score 92.1 87.9 - 96.3 99.9 97.2 - 102.6 0.001
Motor score 92.6 86.9 - 98.2 96.6 94.1 - 99.1 0.190
BSID-III = Bayley Scales of Infant Development version III; CI = confidence interval.
*p-value determined using an independent t-test.
Table 3. Classifications of ‘at-risk’ or ‘delayed’ status according to BSID-III subscale scores of 84 infants with neonatal hypoxic 
ischaemic encephalopathy (NHIE group) and 64 unaffected infants (control group)
At-risk status (score <85) Delayed status (score <70)
Subscale NHIE group, n (%) Control group, n (%) p-value* NHIE group, n (%) Control group, n (%) p-value*
Cognitive 18 (21.4) 14 (22.2) 0.94 12 (14.3) 0 <0.001
Language 23 (27.4) 6 (9.3) 0.006 8 (9.5) 0 0.01
Motor 22 (26.2) 5 (7.8) 0.005 13 (15.5) 0 <0.001
BSID-III = Bayley Scales of Infant Development version III.
*p-value determined using χ2 analysis.
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reduce the incidence of intrapartum hypoxia. Previous results have 
highlighted that a significant number of cases of perinatal asphyxia 
in resource-limited settings are preventable.[19] Issues including 
inadequate training and insufficient numbers of healthcare workers, 
high patient loads, inadequate ambulance services and lack of 
operating theatres result in delays in the transport of women in labour 
to proper health facilities, and in decisions to conduct caesarean 
section deliveries.[2] The provision of sufficient resources is therefore 
necessary for the appropriate care of mothers and babies, to prevent 
neonatal mortality and morbidity.[2] From a paediatric perspective, 
ensuring prompt and effective neonatal resuscitation at all levels 
of care would greatly improve outcomes related to intrapartum 
hypoxia. [20] Evidence indicates that basic neonatal resuscitation is 
beneficial, and is possible even in resource-limited settings.[20]
There are a number of challenges to providing TH in a resource-
limited setting, including the arrival of neonates at the cooling centre 
after the 6-hour postpartum window, shortages of staff and equipment, 
and limited availability of ventilation facilities. However, results from 
a study conducted in Morocco suggest that TH is both feasible and 
safe in LMICs.[21] TH has been provided in the public sector in SA for 
several years, but its benefits in resource-limited settings are still being 
debated. In a systematic review and meta-analysis of the benefits of 
TH in LMICs, no reduction in neonatal morbidity was demonstrated, 
and it was concluded that the safety and efficacy of cooling in LMIC 
settings must be confirmed before it can be provided routinely.[8] In 
contrast, a meta-analysis of three studies of low-technology cooling 
methods (gel packs) in intensive care settings showed reductions in 
both mortality and neurodevelopmental handicap in neonates who 
sustained intrapartum hypoxia.[22] However, frequent measurement 
and adjustment of the temperature is required with these methods, so 
these findings are not generalisable to situations with severe resource 
limitations where there are shortages of nursing staff and equipment.
The present study was not primarily designed to determine the 
effects of TH on outcomes associated with NHIE, and was therefore 
not sufficiently powered for this purpose. However, we did observe a 
significant reduction in the occurrence of language disabilities, as well 
as a trend towards lower rates of CP and cognitive delays, in survivors of 
NHIE who had received TH. No increase in the rate of developmental 
delay or disability was observed in the TH group compared with the 
non-TH group, suggesting that TH is a safe procedure. A publication 
from Tygerberg Hospital in Cape Town that reviewed all neonates 
with NHIE treated with TH found that 18% of survivors had severe 
neurodevelopmental handicap at 1 year of age.[23] The Tygerberg 
study did not have a control group, but the reported rate of handicap 
is similar to that in the NHIE survivors in the present study, so it is 
unclear whether TH is beneficial in a resource-limited setting. To 
determine the precise benefits of TH in resource-limited settings, 
further research needs to be carried out, such as the ‘hypothermia for 
encephalopathy in low- and middle-income countries’ (HELIX) trial, 
a randomised controlled trial of TH v. standard care that is currently 
underway in Bangladesh, India and Sri Lanka.[24]
Study limitations
This study was conducted at a single centre, and the numbers in the 
sample are small. Much larger study populations are required to fully 
evaluate the consequences of neonatal NHIE, particularly CP. The 
small scale of the current study did not enable in-depth analysis of the 
effects of TH on different grades of NHIE. A multicentre collaborative 
study that is adequately powered to evaluate these outcomes is 
recommended. The diagnosis and grading of NHIE in the current 
study was not standardised, and aEEG and MRI investigations were 
not available. Although a reasonable rate of follow-up was achieved, 
it is possible that those who defaulted could have been handicapped, 
which is a potential source of bias in the results.
Generalisability
This study was conducted in a relatively well-resourced setting and 
the findings may not be generalisable to under-served settings in the 
rest of sub-Saharan Africa, where the rates of handicap and CP are 
likely to be far higher.
Conclusions
Perinatal asphyxia and consequent NHIE is an important cause of 
developmental delays, including CP, in infants in sub-Saharan Africa. 
Measures to prevent and treat this condition should be prioritised. 
Further research needs to be conducted to establish whether TH 
reduces neurodevelopmental handicap and mortality in resource-
limited settings. Other research questions include the selection of 
appropriate candidates for TH, adjuvant therapies appropriate for 
low-resourced settings, whether or not TH should be provided 
without mechanical ventilation, and the cost benefit of TH in low-
resourced settings.
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Table 4. TH and handicap among survivors of neonatal hypoxic ischaemic encephalopathy
Variable TH (N=49), n (%) No TH (N=35), n (%) p-value*
Cerebral palsy 5 (10.2) 8 (22.9) 0.11
Motor delay 5 (10.2) 8 (22.9) 0.11
Language delay 2 (4.1) 6 (17.1) 0.04
Cognitive delay 5 (10.2) 7 (20.0) 0.21
TH = therapeutic hypothermia.
*p-value determined using χ2 analysis.
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